A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies (CaDAnCe-101)
NCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 05858164 Brief Summary Researchers are looking for a better way…
Read more arrow_forwardNCT 03165734 Brief Summary This study (study ID PAC203 North America; PAC303…
Read more arrow_forwardNCT 04771130 Brief Summary The study will determine the safety, tolerability, recommended…
Read more arrow_forwardNCT 04419649 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05384626 Brief Summary Phase 1/2, dose escalation and expansion study designed…
Read more arrow_forwardNCT 05936359 Brief Summary This study is being conducted to evaluate…
Read more arrow_forwardNCT 06351631 Brief Summary The primary purpose of the study is…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 03662126 Brief Summary This study evaluates KRT-232, a novel oral small…
Read more arrow_forward